Making a difference, patient by patient

US WorldMeds is a specialty pharmaceutical company that develops, licenses, and brings to market unique healthcare products designed to improve the lives of patients with challenging conditions and unmet medical needs

Patients are key to everything that we do at US WorldMeds


We will remain a sustainable, privately held specialty pharmaceutical company.


We will develop, license, and market meaningful and accessible healthcare products that improve lives and result in a thriving community of patients, employees, and shareholders.


We will embrace a culture that values honesty, creativity, and action, integrity in relationships, a passion for success, and good stewardship of Company resources. We will endeavor to develop, recognize, reward, and retain teammates who deliver results and embody our Vision and Mission.

Our people bring US WorldMeds to life

The leadership team at US WorldMeds

Paul Breckinridge "Breck" Jones
Chief Executive Officer

Founder and Member of the Board of Directors

H. Lee Warren, Jr
Chief Operating Officer

Over 25 years of experience in Pharmaceutical Operations, Sales Management, Marketing and National Accounts

George Digenis, PhD
Chief Scientific Officer

Professor Emeritus of Medicinal Chemistry at University of Kentucky College of Pharmacy

Henry van den Berg, MD
Senior Vice President

25 years of experience in Medical Affairs and Marketing

Stephanie Montgomery, SPHR
Vice President, Finance and Human Resources

20 years of experience in Operational Accounting, Finance and Development, and Human Resources

Gary Grote
Vice President, Market Access

Over 35 years in the pharmaceutical industry, with over 20 years of experience in managed care

Kristen Gullo
Vice President, Development and Regulatory Affairs

Over 10 years of experience in Pharmaceutical Development Strategy, Clinical Operations and Regulatory Affairs

Corey Boone
Compliance Officer